Cargando…
Current strategies in engaging oncolytic viruses with antitumor immunity
Oncolytic virotherapy has produced promising yet limited results in preclinical and clinical studies. Besides direct oncolytic activity, a significant therapeutic mechanism of oncolytic virotherapy is the induction of tumor-specific immunity. Consequently, the efficacy of oncolytic viruses can be im...
Autores principales: | Boagni, Drew Ashton, Ravirala, Divya, Zhang, Shaun Xiaoliu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Gene & Cell Therapy
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8411207/ https://www.ncbi.nlm.nih.gov/pubmed/34514092 http://dx.doi.org/10.1016/j.omto.2021.05.002 |
Ejemplares similares
-
Co-delivery of novel bispecific and trispecific engagers by an amplicon vector augments the therapeutic effect of an HSV-based oncolytic virotherapy
por: Ravirala, Divya, et al.
Publicado: (2021) -
Single-cell RNA sequencing reveals a strong connection between Gadd45g upregulation and oncolytic HSV infection in tumor tissue
por: Ravirala, Divya, et al.
Publicado: (2021) -
Updates to the antitumor mechanism of oncolytic virus
por: Bai, Yang, et al.
Publicado: (2019) -
Aptamers Enhance Oncolytic Viruses’ Antitumor Efficacy
por: Dymova, Maya A., et al.
Publicado: (2022) -
Expression of DAI by an oncolytic vaccinia virus boosts the immunogenicity of the virus and enhances antitumor immunity
por: Hirvinen, Mari, et al.
Publicado: (2016)